172 related articles for article (PubMed ID: 11589822)
1. Comparison of NNRTIs in antiretroviral-naïve patients.
Arribas J
Int J STD AIDS; 2001 Nov; 12 Suppl 4():3-9. PubMed ID: 11589822
[No Abstract] [Full Text] [Related]
2. Comparison of NNRTIs in antiretroviral-experienced patients.
Maggiolo F
Int J STD AIDS; 2001 Nov; 12 Suppl 4():10-7. PubMed ID: 11589823
[No Abstract] [Full Text] [Related]
3. Nevirapine or efavirenz combined with two nucleoside reverse transcriptase inhibitors compared to HAART: a meta-analysis of randomized clinical trials.
Torre D; Tambini R; Speranza F
HIV Clin Trials; 2001; 2(2):113-21. PubMed ID: 11590519
[TBL] [Abstract][Full Text] [Related]
4. [CROI--presentation of new study results. In a comparison of NNRTI nevirapine is equally effective].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():91. PubMed ID: 15373068
[No Abstract] [Full Text] [Related]
5. Protease inhibitor-sparing regimens: new evidence strengthens position.
Moyle GJ
J Acquir Immune Defic Syndr; 2003 Jun; 33 Suppl 1():S17-25; quiz S26-8. PubMed ID: 12946062
[No Abstract] [Full Text] [Related]
6. [Efavirenz--comprehensive status of studies].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():79-81. PubMed ID: 16385886
[No Abstract] [Full Text] [Related]
7. The role of NNRTIs in antiretroviral combination therapy: an introduction.
Nelson M
Int J STD AIDS; 2001 Nov; 12 Suppl 4():1-2. PubMed ID: 11589821
[TBL] [Abstract][Full Text] [Related]
8. Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study.
Manfredi R; Calza L; Chiodo F
J Acquir Immune Defic Syndr; 2004 Apr; 35(5):492-502. PubMed ID: 15021314
[TBL] [Abstract][Full Text] [Related]
9. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
van Leth F; Lange JM
Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943
[TBL] [Abstract][Full Text] [Related]
10. [Results of the AIDS-In-Europe Study. Non-nucleoside reverse transcriptase inhibitor does not equal non-nucleoside reverse transcriptase inhibitor].
MMW Fortschr Med; 2001 Apr; 143 Suppl 1():39. PubMed ID: 11373776
[No Abstract] [Full Text] [Related]
11. Nevirapine found to be as effective as efavirenz.
TreatmentUpdate; 2003; 15(2):3-4. PubMed ID: 12693360
[No Abstract] [Full Text] [Related]
12. Other issues: penetration into sanctuary sites, immune reconstitution and NNRTI sequencing.
Stellbrink HJ
Int J STD AIDS; 2001 Nov; 12 Suppl 4():25-32. PubMed ID: 11589825
[No Abstract] [Full Text] [Related]
13. HIV/AIDS news: comparable anti-HIV antiviral efficacy of Viramune and Efavirenz--the Lancet publishes first large-scale comparison study.
Meyer-Kleinmann J
Infection; 2004 Jun; 32(3):7. PubMed ID: 15230276
[No Abstract] [Full Text] [Related]
14. NNRTIs compared in switch group.
AIDS Patient Care STDS; 2002 Jun; 16(6):302. PubMed ID: 12133265
[No Abstract] [Full Text] [Related]
15. Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients.
Cuzin L; Pugliese P; Bugnon F; Delpierre C; Cua E; Billaud E; Massip P; Raffi F; Dellamonica P
HIV Med; 2005 Nov; 6(6):388-95. PubMed ID: 16268820
[TBL] [Abstract][Full Text] [Related]
16. Nevirapine plus efavirenz plus didanosine: a simple, safe, and effective once-daily regimen for patients with HIV infection.
Jordan WC; Jefferson R; Yemofio F; Tolbert L; Conlon V; Carroll H; Green DC; Green A; Green R
J Natl Med Assoc; 2003 Dec; 95(12):1152-7. PubMed ID: 14717471
[TBL] [Abstract][Full Text] [Related]
17. Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir.
Abgrall S; Yeni PG; Bouchaud O; Costagliola D;
AIDS; 2006 Oct; 20(16):2099-106. PubMed ID: 17053356
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting adherence and convenience in antiretroviral therapy.
Lafeuillade A
Int J STD AIDS; 2001 Nov; 12 Suppl 4():18-24. PubMed ID: 11589824
[No Abstract] [Full Text] [Related]
19. Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes.
Chiesa E; Bini T; Adorni F; Capetti A; Rizzardini G; Faggion I; Mussini C; Sollima S; Melzi S; Bongiovanni M; Tordato F; Cicconi P; Castelnuovo B; Rusconi S; d'Arminio Monforte A
Antivir Ther; 2003 Feb; 8(1):27-35. PubMed ID: 12713061
[TBL] [Abstract][Full Text] [Related]
20. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():58-60. PubMed ID: 15373051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
